This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Vegpro Group: crecer en armonía
Bell, David E.; Milder, Brian; Shelman, Mary L.Case HBS-508S19MarketingVegpro, una empresa de horticultura, es el mayor exportador de verduras frescas y flores a los mejores supermercados en el Reino Unido y Europa de Kenia. En 2007, el negocio de Vegpro se ve amenazada por la creciente preocupación de los consumidores sobre el impacto ambiental de la producción de alimentos y el transporte, incluidos los "food miles". El caso describe el crecimiento de la compañía, que incluye el uso de la tierra y la propiedad de ...Starting at €8.20
-
Vegpro Group: Growing in Harmony, Teaching Note
Bell, David E.; Shelman, MaryTeaching Note HBS-508106-EMarketingTeaching Note for [508-001].Starting at €0.00
-
Social Business at Novartis: Arogya Parivar, Teaching Note
Kramer, Mark R.; Porter, Michael E.Teaching Note HBS-719426-EStrategyTeaching note for case 715411.Starting at €0.00
-
Vegpro Group: Growing in Harmony
Bell, David E.; Milder, Brian; Shelman, Mary L.Case HBS-508001-EMarketingVegpro, a horticulture company, is Kenya's largest exporter of fresh vegetables and flowers to top supermarkets in the U.K. and Europe. In 2007, Vegpro's business is threatened by growing consumer concern about the environmental impact of food production and transport, including "food miles". The case describes the company's growth, which includes the use of owned land and outgrowers for production, the addition of value-added processing to obtai...Starting at €8.20
-
K&N's: Health and Happiness for Pakistan, Teaching Note
Bell, David E.; McLoughlin, Damien P.; Shelman, MaryTeaching Note HBS-513077-EStrategyTeaching Note for 512002Starting at €0.00
-
Social Business at Novartis: Arogya Parivar
Porter, Michael E.; Kramer, Mark R.; Lane, DavidCase HBS-715411-EStrategyLate in 2013, Novartis CEO Joseph Jimenez was considering how and whether to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India, while expanding access to medicine and health information to millions of Indian villagers.Starting at €8.20
-
K&N's: Health and Happiness for Pakistan
Bell, David E.; McLoughlin, Damien P.; Shelman, MaryCase HBS-512002-ETo maximize their effectiveness, color cases should be printed in color. In 2011 Khalil and Adil Sattar are considering growth opportunities for K&N's, their family business that is the market leader for processed chicken and value-added chicken products in Pakistan. This position has been built through a strategy of vertical integration, product innovation, and branding. K&N's has also developed its own chain of retail "Chicken Stores" to promot...Starting at €8.20
-
Diageo: Innovating for Africa, Teaching plan
Bell, David E.; McLoughlin, Damien P.; Shelman, Mary; Otazo, AndrewTeaching Note HBS-515056-EStrategyThis teaching plan is designed to help students understand the challenges and opportunities of launching products and building businesses in developing markets.Starting at €0.00
-
Pak Sweets: Managing a Diverse Workforce
Maria Khan; Zunaira Saqib; Nataliya Farrukh; Fatima Tanvir; Kahaf PashaCase IVEY-9B16C017-ELeadership and People Management, StrategyIn 2014, the chief executive officer (CEO) and owner of Pak Sweets was worried about diversity issues in his organization. The sweets-making factory, once a one-room business and now a full-fledged factory in Rawalpindi, Pakistan, was highly dependent on blue-collar workers. Each production process required workers with diverse skills, so the company hired employees from different provinces of Pakistan, representing multiple ethnicities. The ethn...Starting at €8.20
-
PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World
Schulman, Kevin A; Moodley, Sashidaran; Vasudevan, AnantCase HBS-317103-EEntrepreneurshipPharmAccess is an Amsterdam based NGO working to support the development of the private health care market in Africa. This work is critical as over 50% of care is delivered through the private sector, but well-intentioned efforts to address global health through the public sector have the unintended consequence of crowding-out capital formation in the private sector. PharmaAccess is working to crowd-in funding instead through the development of a...Starting at €8.20